YAP1 and cancer: One key question is whether YAP/TAZ activation can serve as a general anti-aging strategy, despite the potential risks of developing other age-related diseases such as cancer and tissue fibrosis, given the pro-proliferative and profibrotic roles of YAP/TAZ.